The Precision Medicine Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The Precision Medicine Global Market Report 2025 indicates a significant growth trend. The market size has expanded from $80.15 billion in 2024 to an expected $88.73 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 10.7%.
The Precision Medicine Global Market Report 2025 projects that by 2029, the precision medicine market size will grow to $129.37 billion, with a compound annual growth rate (CAGR) of 9.9%.
Download Your Free Sample of the 2025 Precision Medicine Market Report and Uncover Key Trends Now!The key drivers in the precision medicine market are:
• A rise in the geriatric population, contributing to the prevalence of chronic diseases
• Increasing instances of cancer among the global population
• High potential of emerging economies for healthcare diversification and advancement
• Emergence of novel pathogenic infestations fostering the need for enhanced diagnostic methods
• Significant spending in research and development in the healthcare sector
• Increase in overall healthcare expenditure
• Adoption of artificial intelligence technologies in healthcare for improving competitiveness
• Emphasis on offering diagnosis and personalized treatment strategies for immune-mediated diseases
• Increased investment in research and development activities for innovative solutions
• Strategic collaborations and partnerships among technology and healthcare entities to improve product portfolios.
The precision medicine market covered in this report is segmented –
1) By Technology: Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics, Other Technology
2) By Application: Oncology, Respiratory Diseases, Central Nervous System Disorders, Immunology, Genetic Diseases, Other Applications.
3) By End-Use: Pharmaceutical Companies, Diagnostic Companies, Healthcare And IT Firms, Others
The key trends in the precision medicine market are:
• The adoption of artificial intelligence technologies for enhancing competitiveness is a significant trend.
• A new trend includes providing diagnosis and personalized treatments for immune-mediated diseases.
• An increase in research and development activities is an emerging trend shaping the future of the precision medicine market.
• Collaborations and partnerships with technology and healthcare entities to improve product portfolios is an identified future trend.
Major companies in the precision medicine market are:
• Quest Diagnostics
• Thermo Fisher Scientific Inc.
• Roche Holding AG
• Medtronic plc
• Novartis AG
• Pfizer Inc.
• Qiagen
• AstraZeneca plc.
• Abbott Laboratories
• Nordic Bioscience A/S
• Takeda Pharmaceutical Company Ltd.
• Otsuka Pharmaceutical Co. Ltd.
• Daiichi Sankyo
• China National Pharmaceutical Group Co., Ltd.
• GE Healthcare
• Randox Laboratories
• Almac Group
• Sun Pharma
• Nichi-Iko Pharmaceutical Co., Ltd.
• Daewoong Pharmaceutical Co.,Ltd
• GlaxoSmithKline
• Teva UK Limited
• Vectura Group
• Merck & Co.
• Boehringer Ingelheim
• Mylan
• Zentiva
• Sanofi
• Apotex
• Gilead Sciences
• Bayer
• AbbVie Inc.
• Amgen
• Janssen Pharmaceutica
• Accord Healthcare Inc.
• Acerus Precision Medicine Corporation
• AA Pharma Inc
• Sanfer
• LABORATORIOS SENOSIAIN SA DE CV
• Siegfried Rhein
• Biocrates LifeSciences
• Nanostring Technologies
• Tepnel Pharma Services
• Intomics
• Silicon Biosystems
• EMS Pharma
• Eurofarma
• Biolab Farmaceutica
• Cristalia
• União Quimica
North America was the largest region in the precision medicine market in 2024